Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gordon Parry

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal for Immunotherapy of Cancer|September 12, 2024
Regression of renal cell carcinoma by T cell receptor-engineered T cells targeting a human endogenous retrovirusStefan Barisic, Elizabeth M Brahmbhatt, Elena Cherkasova, et al.
Cancer Research|September 17, 2005
Identification of a novel prostate tumor target, mindin/RG-1, for antibody-based radiotherapy of prostate cancerRenate Parry, Doug Schneider, Debra Hudson, et al.
Pathology Research International|December 15, 2010
Analytical Validation of a Highly Quantitative, Sensitive, Accurate, and Reproducible Assay (HERmark) for the Measurement of HER2 Total Protein and HER2 Homodimers in FFPE Breast Cancer Tumor SpecimensJeffrey S Larson, Laurie J Goodman, Yuping Tan, et al.
Breast Cancer Research and Treatment|August 21, 2013
HER3, p95HER2, and HER2 protein expression levels define multiple subtypes of HER2-positive metastatic breast cancerAllan Lipton, Laurie Goodman, Kim Leitzel, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal for Immunotherapy of Cancer|September 12, 2024
Regression of renal cell carcinoma by T cell receptor-engineered T cells targeting a human endogenous retrovirusStefan Barisic, Elizabeth M Brahmbhatt, Elena Cherkasova, et al.
Cancer Research|September 17, 2005
Identification of a novel prostate tumor target, mindin/RG-1, for antibody-based radiotherapy of prostate cancerRenate Parry, Doug Schneider, Debra Hudson, et al.
Pathology Research International|December 15, 2010
Analytical Validation of a Highly Quantitative, Sensitive, Accurate, and Reproducible Assay (HERmark) for the Measurement of HER2 Total Protein and HER2 Homodimers in FFPE Breast Cancer Tumor SpecimensJeffrey S Larson, Laurie J Goodman, Yuping Tan, et al.
Breast Cancer Research and Treatment|August 21, 2013
HER3, p95HER2, and HER2 protein expression levels define multiple subtypes of HER2-positive metastatic breast cancerAllan Lipton, Laurie Goodman, Kim Leitzel, et al.
Pageof 2